Thermosensitive poloxamer-based injectables as controlled drug release platforms for veterinary use: development and in-vitro evaluation by Bermudez, Jose Maria & Grau, Ricardo Jose Antonio
International Research Journal of Pharmacy and Pharmacology  Vol. 1(6) pp. 109-118, September  2011 
Available online http://www.interesjournals.org/IRJPP 
Copyright © 2011 International Research Journals 
 
 
Full Length Research Paper 
 
Thermosensitive poloxamer-based injectables as 
controlled drug release platforms for veterinary use: 
Development and in-vitro evaluation 
 
Bermudez J.M.1* and Grau R.2 
 
1
Instituto de Investigaciones para la Industria Química (INIQUI-CONICET), Universidad Nacional de Salta, Buenos Aires 
177, A4402FDC Salta, Argentina 
2
Instituto de Desarrollo Tecnológico para la Industria Química (INTEC-CONICET), Universidad Nacional del Litoral, 
Güemes 3450, 3000 Santa Fe, Argentina 
 
Accepted 18 August, 2011. 
 
The aim of this work was to explore the potential of combining two different poloxamers (P407 and 
P188) with κ-carrageenan and sodium chloride for their utilization in the design of thermosensitive 
injectable depot systems for drug release. These delivery platforms were designed by combination 
of two different poloxamers (P407 and P188) with κ-carrageenan and sodium chloride. The addition 
of 10-15% w/w P188 in the poloxamer solution containing 28% w/w P407 allowed optimal gelation 
temperatures (24-28 °C) and a quick gelation process (30 s). The addition of 0.1% w/w of κ-
carrageenan increased 3-fold the gel strength and did not change gelation temperature, compared 
with P407/P188 (28/15% w/w) alone. On the other hand, sodium chloride increased the gel strength 
and decreased the gelation temperature as a function of its concentration. In in-vitro release 
experiments, κ-carrageenan decreased the release rate of progesterone and reduced significantly 
the gel erosion in 48 h. This study demonstrates that addition of κ-carrageenan and sodium chloride 
into poloxamers blends can be considered a useful tool to design thermosensitive platforms, if 
added in suitable amounts. In conclusion, this system offers a promising alternative to development 
of injectable depot controlled drug release platforms for veterinary use. 
 





Polymeric drug delivery is the most widely studied area of 
drug delivery in recent years (Kwon and Kim 2005). 
Polymers can be manipulated to possess certain 
properties that can meet specific criteria for the designe 
of suitable delivery systems. Polymeric drug delivery 
systems may provide advantages such as (i) increased 
efficacy, (ii) reduced side effects and toxicity, and (iii) 
convenience (Kwon and Kim 2005). The success of the 
sustained release of a drug for the required duration of 
time with the optimum release mode depends on various 
factors, such as the physicochemical properties of the 
drug and the drug-carrier matrix in addition on the dosage 
form and administration route (Hosseinkhani et al., 2009, 
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have high academic, clinical, and practical impacts on 
gene therapy, cell and molecular biology, pharmaceutical 
and food industries, and bio-production (Hosseinkhani 
and Hosseinkhani, 2009). Controlled release dosage 
forms are important products in veterinary medicine 
owing to several advantages which include better animal 
compliance, lower side effects and convenience for 
farmers. Controlled release parenteral formulations are 
classified by their physical form into liquids (aqueous-
based or oily systems), in situ forming solids and solids 
(implants) (Medlicot et al., 2004). In situ forming systems 
for intramuscular use have been recently developed for 
the production of sustained release systems and 
represent an attractive alternative to replace 
implantations, temporary prosthesis or controlled release 
microspheres (Matscheke et al., 2002). The importance 
of in situ forming matrix systems is related to several 
advantages such as, for instance, easy application, use  




of non-toxic carriers, simple and economical elaboration 
(Matschke et al., 2002), prolonged residence time and 
controlled drug release. Moreover these systems avoid 
painful surgical procedures to insert solid implants. For all 
these reasons, the development of these novel platforms 
in the veterinary field is of particular interest both from the 
scientific and industrial perspective. Particularly, a 
polymer solution capable of gelling in situ at a 
temperature close to the physiological one might be 
attractive for the development of drug delivery systems. 
The poloxamers, specially poloxamer 407 (P407) and 
poloxamer 188 (P188), are thermosensitive materials 
frequently used due to their advantages such as, 
availability, easy gel preparation methods, good 
compatibility with several drugs and pharmaceutical 
excipients (Koffi et al., 2006) and high solubilizing 
capacity of drugs (Albertini et al., 2009; Albertini et al., 
2010). Poloxamer gels have been widely investigated in 
the human pharmaceutical field as drug release systems 
since they are relatively easy to obtain and generally 
recognized as safe (Mayol et al., 2008).  It is well known 
that poloxamer solutions present the reverse thermal 
gelation phenomenon, which is characterized by a sol-gel 
transition temperature (Tgel). Below this temperature, the 
sample remains fluid and above it the solution becomes 
semi-solid (Matschke et al., 2002). This unique property 
depends on the concentration of the poloxamer and on 
the presence of additives such as salts and other 
polymers (Mayol et al., 2008, Liu et al., 2009, Gratieri et 
al., 2010). However, there are also disadvantages 
associated to poloxamer's gel applications as drug 
delivery systems such as limited stability, poor 
mechanical properties and short residence times due to 
its rapid dissolution when placed within biological 
environments (Nanjawade et al., 2007). Some efforts of 
poloxamer chemical modification reported in literature 
showed promising results like slower gel erosion when 
used as injectable systems, although chemical 
modifications usually incorporate toxic residues, so they 
are not widely accepted (Bromberg and Ron, 1998; Cohn 
et al., 2003). Addition of natural or semi-natural 
macromolecules to poloxamer's gels is another 
alternative to obtain gels systems with appropriate 
mechanical and release properties. Furthermore, they are 
more profitable, convenient and safe. To this aim, in this 
work κ-carrageenan (CA) was selected as natural 
polysaccharide due to its controlled released properties 
(Liu et al., 2009). Carrageenan hydrocolloid is obtained 
by extraction with water or aqueous alkali from some 
members of the Rhodophyceae class (red seaweed). 
Carrageenans are classified into three families (λ-, ι- and 
κ-) according to the position of sulfate groups and the 
presence or absence of anhydrogalactose.  
The scope of the present contribution was to explore 
the potential of novel thermosensitive drug delivery 
platforms designed by combination of two different 





sodium chloride for application as an injectable depot 
system for veterinary use. Rheological measurements 
were performed to characterize the viscoelastic 
properties, gelation temperature and gel strength. The 
effect of sodium chloride and κ-carrageenan on gelation 
temperature and gel strength of the injectable depot 
system was studied. Progesterone was used as a model 
drug to test the feasibility of these platforms as injectable 
depot systems. The gel erosion and in vitro release 
profiles were also evaluated. 
 
 
MATERIALS AND METHODS  
 
Poloxamers (P407, P188) were a gift of BASF 
(Germany), κ-carrageenan was kindly provided by 
Soriano (Buenos Aires, Argentina), progesterone was 
supplied by Farmabase, (Rovereto, Italy) and sodium 
chloride by Carlo Erba Reagents (Milan, Italy). All 
reagents were used without any further purification 




Preparation of thermosensitive gel 
 
Poloxamer gels were prepared by the “cold method” 
described by Schmolka (1972), which allows easier 
poloxamer dissolution and avoids possible alterations 
produced by heat. An appropriate amount of poloxamer 
was added to a cold water solution (5-10 °C) while 
keeping constant agitation with a magnetic stirring rod. 
To ensure complete dissolution, poloxamer solutions 
were kept in a refrigerator during 24 h. To prepare κ-
carrageenan and sodium chloride solutions, appropriate 
amounts of these additives were weighed and dissolved 
in pure water at 80 °C and 25 °C, respectively.  
Finally, polymeric platforms were loaded with 
micronized progesterone (1% w/w), by direct dispersion 
of the drug in the polymer blend. Magnetic continuous 
stirring was used to homogenize the mixture. The 
analyzed formulations are reported in Table 1.  
 
 
Visual measurement of gelation temperature (Tgel) 
 
A transparent- glass reactor containing 50 ml of 
poloxamer gel was coupled to a refrigerated circulator 
bath. A K-type temperature sensor was connected to a 
digital thermometer and immersed in the poloxamer gel, 
whith heating rate at 1 °C/min and continuous stirring rate 
at 80 rpm. Tgel was determined as the temperature 
displayed on the thermometer when the bar magnet 
stops moving due to gelation (Choi et al. 1998). This 
method is simple and easy to perform but shows 
significant limitations because the sol-gel transition 
occurs within a large temperature interval, thus the Tsol- 









Gelation temperature (°C) Gel strenght 
Visual 
determination 
Rheology F (s) 
28 17.5 ± 1.3 18.2 ± 0.7 2.0 ± 1.1 
28/10 26.6 ± 1.6 25.5 ± 1.0 13.3 ± 1.2
 
 
28/15 27.9 ± 1.9 28.2 ± 0.8 72.7
 
± 4.3 
28/10/0.1 24.6 ± 0.9 25.8 ± 0.7 64.0
 
± 4.5 
28/15/0.1 26.4 ± 0.9 27.7 ± 0.9 206.0
 
± 6.2 
28/15/0.1/0.2 26.1 ± 1.5 27.9 ± 0.7 245.8 ± 9.8 
28/15/0.1/0.4 24.8 ± 1.6 23.1 ± 1.0 248.1 ± 7.4 
 
 
gel value is greatly influenced by experimental set-up 
conditions (Durmotier et al., 2006). For this reason the 
rheological method, afterwards described, was also used 






Oscillatory rheometry was performed for all the evaluated 
formulations using a rheometer MCR301 controlled 
stress (Anton Paar, Germany). Experiments were 
performed to assess changes in the rheological 
parameters as function of temperature, by oscillatory 
measurements at a fixed frequency of 10 Hz and with 
stress amplitude to ensure linear viscoelasticity 
(nondestructive dynamic conditions). The study was 
conducted using the cone-plate geometry (50 mm 
diameter) in a temperature range of 10 to 37 °C with a 
heating rate of 1 °C/min. The rheometer was also used to 
characterize the time-dependent changes in the elasticity 
modulus at 37 °C. 
Two moduli were calculated from the rheological data: 
the storage modulus or elastic modulus (G´) and the loss 
modulus or viscous modulus (G´´). G’ gives information 
about the stored elastic energy, while G’’ describes the 
viscous character or the energy dissipated as heat. 
Gelation temperature is defined as the temperature at 
which the values of both moduli were equal, reflecting 
similar elastic and viscous properties (“G´ G´´ crossover” 
criterion) (Durmotier et al., 1991).  
 
 
Measurement of gel strength  
 
50 ml of poloxamer gel were poured in a 100 ml 
graduated cylinder and gelled in a thermostated bath at 
37 °C. The device for measuring gel strength (weight 33 
g) was placed onto poloxamer gel. The gel strength was 
determined as the time that the device took to sink 5 cm 
down   through   the  poloxamer  gel.  If  the  time   would 
exceeded five minutes, several  weights  would be placed 
 on top of the device (Choi et al., 1998). 
 
 
In vitro release experiment 
 
The release experiments were performed using the 
membraneless model since this procedure allows direct 
contact between gel and release medium, and gel 
erosion can also be considered. In membraneless model, 
two phenomena are involved: the fickian diffusion of the 
drug and the dissolution of poloxamer. This model has 
been widely used for poloxamer based gels (Zhang et al., 
2002; Liu et al., 2007; Cafaggi et al., 2008; Liu et al., 
2009), and specially for injectable formulations (Moore et 
al., 2000; Paavola et al., 2000; Amiji et al., 2002). 
Briefly, the vial containing the loaded gel with 
progesterone was placed in a thermostatic bath (37 ± 
0.05 ºC) until a semisolid gel was formed. Then, 10 ml of 
release medium pre-equilibrated at 37 ± 0.05 ºC were 
carefully poured on the surface of the gel. To simulate 
physiological conditions sodium chloride 0.9% w/w was 
used. At predetermined time intervals, the release 
medium was completely replaced by fresh medium kept 
at 37 ºC and formulations were weighed to calculate the 
proportion of dissolved gel. The concentration of 
progesterone in the release medium was determined by 
UV spectrophotometry at maximum wavelength 
absorbance, 245 nm (UV2 Spectrometer Unicam, New 
York, USA). 
The results are expressed as a percentage of 
progesterone released. Progesterone release profiles 
from each gel formulation were analyzed using the power 
law model, 
 
where Mt and M∞ are the absolute cumulative amounts of 
progesterone released at time t and infinite time, 
respectively. The k is a parameter dependent upon 
structural and geometric characteristic of the system 
(Tarvainen et al., 2002). By fitting experimental results of 
Mt and M∞ in the time domain, exponent n was  




                         
 
Figure 1. Elastic (G´) and viscous (G´´) moduli as a function of temperature for gel 28% 
poloxamer 407. Results are the means of three measurements. SD was always lower 
than 10%. Error bars are omitted for clarity purpose 
 
 
calculated. This value provides information about the 
drug release mechanism from the platform (Takka et al., 
2001; Bermudez et al., 2008). 
All the experiments were carried out at least in triplicate 




RESULTS AND DISCUSSION 
 
The interest of new injectable drug delivery systems has 
been sparked by the advantages these delivery systems 
possess. Injectable polymeric matrices, which are already 
widely used as sustained drugs release formulations, 
have also been applied in tissue engineering for its 
potential use as a cell delivery carrier or supportive matrix 
(Hosseinkhani et al., 2006a,b,c). Interest in injectable 
scaffolds is mainly related to the fact that they eliminate 
the need for surgical implantation, increasing patient 
compliance (Quaglia, 2008). The field of tissue 
engineering has been benefited significantly by controlled 
release research and technology. Recently, gels 
exhibiting a sol-gel thermosensitive behavior have been 
reported to act as carriers of cells for tissue regeneration 
(Quaglia, 2008). Gelation temperature is the temperature 
at which the liquid phase undergoes the transition from 
sol to gel. If the gelation temperature of the injectable 
depot system is lower than 25 °C, gelation occurs at 
room temperature leading to difficulty in manufacturing, 
handling and administering. If the gelation temperature is 
higher than 37 °C, the injectable depot still remains as a 
liquid at body temperature, resulting in loss of the gel 
immediately after administration.  
The goal of this work was to formulate injectable 
thermosensitive gels made up of poloxamer blends (P407 
and P188) and κ-carrageenan with suitable erosion and 
controlled drug release properties. The viability of these 
platforms as injectable depot systems for veterinary use 
was assessed by studying the gelation temperature, the 
gel strength and the viscoelastic properties. The effect of 
sodium chloride on the rheological properties of 
poloxamer gels was also evaluated. Besides the visual 
evaluation of the studied formulation upon gelification, a 
proper rheological analysis is a valuable technique to 
investigate the gelling process and the viscoelastic 
properties of thermosensitive gels. The oscillatory 
measurements using low oscillating angle became 
appropriate because the gel structure remains intact 
during measurements. This assay gives information 
about dynamic properties, G´, the elasticity modulus, and 
G´´, the viscous modulus. In this study, the moduli were 
measured within the linear region, where the shear force 
of gel depot is small, and then the results might be close 
to the in vivo situation. The gelation temperature (Tgel) 
was identified as the temperature at which G´ and G´´ 
curves intersect each other. 
The gelification temperatures obtained by visual 
determination and by the rheological analysis are 
reported and compared in Table 1. 
Gelation temperature of poloxamer solution containing 
28% of P407 (28) alone was 18.2°C (Figure 1). The 
results obtained indicated that P407 alone could not 
provide the suitable gelation temperature. Gelation 
temperature increased along with the concentration of 
P188. With the addition of 10% and 15% of P188, the 
gelation temperatures increased about 7°C (25.5°C) and  
10°C (28.2°C), respectively (Figure 2). The 
thermogelation results from interactions between different 
segments of the copolymers. As temperature increases, 
poloxamer copolymer molecules aggregate into micelles, 
due to the dehydration of hydrophobic polyoxypropylene 
blocks, which represents the very first step in the gelling 
process. These micelles are spherical  with a  dehydrated 
polyoxypropylene  core  with  an  outer  shell of  hydrated 






Figure 2. Elastic (G´) and viscous (G´´) moduli as a function of temperature for 
gels composed of  poloxamer 407/poloxamer 188 with different  concentrations 
weight / weight. Results are the means of three measurements. SD was 
always lower than 10%. Error bars are omitted for clarity purpose. 
 
 
swollen polyoxyethylene chains. This micellization is 
followed by gelation when the samples are enough 
concentrated. This gelation was attributed to the ordered 
packing of micelles (Durmotier et al., 2006). The addition 
of 0.1% w/w of κ-carrageenan (28/10/0.1) practically did 
not change the gelation temperature with respect to the 
values of the 28/10 and 28/15 poloxamer solutions (Table 
1). In addition, Figure 3 clearly shows the intersection of 
the elastic and viscous moduli of 28/10 and 28/10/0.1 
formulations. Besides a suitable gelation temperature, an 
injectable gel intended for both in situ gelification and 
controlled release should exhibit an adequate 
consistency and strength. The value of gel strength, 
which measures the viscosity of the poloxamer gel at 
physiological temperature, was determined using the 
device described by Choi et al. (1998) and the results are 
reported in Table 1. The addition of P188 increased the 
strength of poloxamer gel. With the addition of 10% 
P188, the gel strength increased from 2 to 13 s and 
adding 15% P188, it was 73 s. It can be observed that a 
little increase in the concentration of P188 in the 
poloxamer gel leads to a great change in the gel strength. 
The gel strength increased also considerably when κ-
carrageenan was incorporated in the formulation. In 
28/15 formulation, the gel strength increased from 73 to 
206 s with the addition of 0.1% carrageenan (Table 1). 
Therefore, κ-carrageenan macromolecules might be able 
to interact with micelles through secondary bonds, such 
as hydrogen bond, reinforcing the structure and therefore 
the mechanical properties of the gel.  
These results indicated that 28/15/0.1 formulation 
resulted the most appropriate one as drug delivery 
platform since it exhibited suitable gelation temperature 
(about 28 °C) and gel strength (about 206 s). Therefore, 
28/15/0.1 was used to study the effect of sodium chloride 
on the mechanical properties of poloxamer gels. The 
formulations P407/P188/CA/NaCl were prepared in the 
following proportions: 28/15/0.1/0.2 % w/w (abbreviated 
28/15/0.1/0.2) and 28/15/0.1/0.4 % w/w (abbreviated 
28/15/0.1/0.4). It was also prepared a formulation 
28/15/0.1 containing 0.9% w/w sodium chloride but it was 
excluded from further investigation because its high 
viscosity at room temperature would make difficult its 
administration as injectable depot.  
It was supposed that sodium chloride could strengthen 
the bonding of cross-linked reticular in the poloxamers 
systems by placing them in the gel matrix, because it 
would interact with poloxamer through strong cross-
linking bonds. This behavior could result  in an increase 
in gel strength and a decrease in gelation temperature 
(Choi et al., 1999). With the addition of 0.2% sodium 
chloride, the gel strength of 28/15/0.1 increased from 206 
to 245 s while gelation temperature did not change. 
When 0.4% of sodium chloride was added, the gel 
strength did not further increase significantly (Table 1) but 
the gelation temperature considerably decreased (from 
about 27 to 23 °C), which is undesirable. Therefore it is 
possible to prepare a suitable injectable depot system 
with a liquid form at room temperature and a gelation 
temperature in the range 25-28 °C, by adjusting the 
contents of sodium chloride at 0.2% w/w. 
Another important characteristic for in situ gelling 
injectable systems to be considered is the gelation time. 
In fact, after intramuscular application, a short gelation 
time would be advantageous, since the risk of dilution 
with physiological fluid and the possibility of local 
drainage at the site of application are reduced.  Gelation 
process for the evaluated systems was found to occur 
very quickly. Gelation time describes time-dependent 
changes occurring during the gelation. It is defined as the 








Figure 3. Elastic (G´) and viscous (G´´) moduli as a function of temperature for 
gels composed of poloxamer 407/poloxamer 188/carrageenan with different 
concentrations weight / weight. Results are the means of three measurements. SD 





Figure 4. Elastic (G´) and viscous (G´´) moduli at 37 °C as a function of time for 
gels composed of poloxamer 407/poloxamer 188/carrageenan/sodium chloride 
with different concentrations weight / weight. Results are the means of three 




time after which the elasticity modulus becomes higher 
than the viscosity modulus at a constant temperature 
above the transition. For example, the gelation time of 
P407/P188/CA (28/15/0.1) and P407/P188/CA/NaCl 
(28/15/0.1/0.2) was observed at about 30 s (Figure 4). 
Another chemical-physical property useful to evaluate 
the behavior of the gel is its viscosity. It was found that 
the viscosity of the formulations was significantly 
influenced by the content of κ-carrageenan and sodium 
chloride. As shown in Figure 5, the addition of these 
components, especially sodium chloride, greatly 
increased the viscosity of the poloxamer formulations at 
low temperature. Moreover, the curves of viscosity versus 
temperature obtained for the different formulations 
exhibited the typical behavior of poloxamer gels and 
varied linearly at low temperatures but increased 
substantially in a temperature range of 25-28 °C for 
poloxamer systems. These results are related to the 
analysis of sol-gel transition previously discussed. 
The addition of progesterone to the studied 
formulations did not modify the sol-gel transition 
temperature and the gelation time (data not shown). 
With regard to gel dissolution (erosion) studies and 
progesterone release, physiological solution was used as 
release medium to simulate the environment after the 
intramuscular administration. 






Figure 5. Viscosity as a function of temperature for gels composed of poloxamer 
407/poloxamer 188/carrageenan/sodium chloride with different concentrations 
weight / weight. Results are the means of three measurements. SD was always 





Figure 6. Erosion of thermosensitive gels composed of poloxamer 
407/poloxamer 188/carrageenan with different concentrations weight / 




To asses the influence of the concentration of 
poloxamer and carrageenan in the erosion of the release 
platform, gels of poloxamer 407, poloxamer 188 and κ-
carrageenan in different proportions (formulations 28/10, 
28/15, 28/10/0.1 and 28/15/0.1) were studied. It was 
observed that erosion was significantly influenced by the 
P188 concentration, decreasing about 12% when 
increasing 5% its concentration for gels without CA 
(Figure 6). This result could be attributed to the increase 
in the number and size of the micelles formed at the  
 
higher polymer concentration. Besides, higher poloxamer 
concentrations could result in a shorter intermicellar 
distance, leading to greater number of cross-links 
between neighboring micelles and a greater number of 
micelles per unit volume (Zhang et al., 2002).  
The erosion decreased significantly for both gels 
containing κ-carrageenan, compared to the poloxamers 
gels 28/10 and 28/15 and it was about 35-40% in 48 h in 
both cases (Figure 6). 
Progesterone is a natural hormone used as 






Figure 7. Profiles of progesterone release from thermosensitive gels 
composed of poloxamer 407/poloxamer 188/carrageenan with different 
concentrations weight / weight: (▲) 28/10%, (■) 28/15%, (∆) 28/10/0.1% and 




Table 2. Data obtained using the fitting model to evaluate the release profiles of progesterone from gels 
composed of poloxamer 407/poloxamer 188/carrageenan 
 
Formulations 






28/10 0.716 ± 0.065 0.189 ± 0.095 Mt/M∞= 0.189t
0.716
 0.995 
28/15 0.744 ± 0.082 0.132 ± 0.084 Mt/M∞= 0.132t
0.744
 0.993 
28/10/0.1 0.755 ± 0.106 0.091 ± 0.074 Mt/M∞= 0.091t
0.755
 0.989 




n = diffusional exponent; k = kinetic parameter; Mt and M∞ are the absolute cumulative amounts of progesterone 
released at time t and infinite time using the power law model 
 
 
contraceptive either alone or combined with an estrogen. 
The reported solubility of progesterone in water in 
ambient conditions is 0.016 mg/ml. Drug release curves 
of progesterone from thermosensitive gels composed of 
poloxamer 407/poloxamer 188/carrageenan are shown in 
Figure 7. As it can be seen, all the formulations were able 
to sustain progesterone release for more than 48 h, 
which is a time period of interest for an intramuscular 
administration for veterinary use. Anyway, the release of 
the drug from these gels was complete within 96 h (data 
not shown). 
The release profile of progesterone from 28/10 gel 
formulation was higher than that of 18/15. The addition of 
κ-carrageenan decreased the release of progesterone  
from the gels containing 10% of P188, but this effect was 
negligible in the gels with 15% of P188 (Figure 7). 
Release data were then processed using the power 
model and results are reported in Table 2. The n values 
obtained were between 0.5 and 1 for all the formulations, 
suggesting that, besides the diffusion mechanism, other 
mechanisms are involved in the kinetic control of drug 
release (Table 2). Therefore, dissolution and relaxation 
polymer processes could be involved in drug release 
mechanism. The poloxamer system is one of the 
swelling-controlled systems, which functions by a process 
of continuous swelling of the polymer carrier that is 
associated with simultaneous or later dissolution of the 
polymer. Poloxamer-carrageenan gels seem to be 
versatile release platforms providing a wide range of 
release rates and erosion varying their composition. This 
could allow new in situ injectable platforms with optimal 
drug release and erosion properties.  
Several important issues must be considered in the 
drug delivery in the veterinary field. The main and most 
important is the overall product cost, which includes 
administration expense. The main driving force for the 
development of novel drug delivery systems intended for 
livestock is given by the reduction of the frequency of 
veterinary services and drug administration, the major 





motions of roundups and the decrease of the stress of 
the animals.  
According to these features, in situ gelling injectable 
systems based on poloxamers P188 and P407 could be 
interesting delivering platforms to study. Poloxamer 
solution containing 28% of P407 alone did not possess 
the appropriate gelling temperature for its application as 
drug delivery system. The addition of 10-15% of P188 
allowed obtaining optimal gelation temperatures. The 
results showed that the addition of κ-carrageenan led to 
an improvement of gel mechanical properties with an 
increase of gel strength and a decrease of gel erosion. 
Sodium chloride reinforced the gel strength and reduced 
the gelation temperature of the gels. Depending on the 
composition of the poloxamer blend, κ-carrageenan 
slowed the progesterone release. This study 
demonstrates that the addition of κ-carrageenan and 
sodium chloride into poloxamers blends can be 
considered a useful tool to design thermosensitive 
injectable depot systems, if added in suitable amounts. 
Finally, the low viscosity of poloxamers systems at low 
temperature makes them easy to be injected 
intramuscularly into the animal body via a syringe, and 
they could be used in warm climates due to the 
reversibility of the gelation process. These encouraging 
results, that need to be further assessed by in vivo 
experiments, show the possibility of using these novel 
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